Large-scale testing (Phase 3)Study completedNCT00200512
What this trial is testing
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 16
Showing 20 of 51 results